Scott Friedman

Scientific Advisor at Sagimet Biosciences

Dean for Therapeutic Discovery, Chief of the Division of Liver Diseases at Mt. Sinai School of Medicine.

Location

New York, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Sagimet Biosciences

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.


Employees

11-50

Links